Antimicrobial resistance and data
In response to the growing public health crisis of antimicrobial resistance (AMR), we ran a short project exploring how to gather and openly share data from antibiotic/AMR surveillance initiatives run by pharmaceutical companies.
Supported by a grant from Wellcome, this project gave an opportunity for us to apply our expertise in developing data infrastructure – the standards, registers, data assets and data governance, and means of sharing data such as data portals – to strengthen the ability and motivation of pharmaceutical companies to share data.
This project allowed us to understand the data practices of pharmaceutical companies, identify challenges, and develop a prototype to showcase what can be done. We hope that this will be the start of a much bigger contribution within the area of AMR, transforming how the sector stewards and creates value from data, contributing to better health outcomes for all.
Read about the project in more detail in this AMR project case study.